Overall | |
---|---|
n = 78 | |
Age (years) | |
Median | 56 |
Range | 40–72 |
>60 years (%) | 28.2 |
Sex | |
Male | n = 69 (88.5 %) |
Female | n = 9 (11.5 %) |
Treatment after TPF (%) | |
RT | n = 69 (88.5 %) |
OP | n = 4 (5.1 %) |
no further treatment due to toxicity | n = 5 (6.4 %) |
Nodal stage cN2c or cN3 | |
Yes | n = 24 (30.8 %) |
No | n = 54 (69.2 %) |
cT4 stage (%) | |
Yes | n = 53 (67.9 %) |
No | n = 25 (32.1) |
Stage of disease | |
AJCC Stage 4 | n = 73 (93.4 %) |
AJCC Stage 3 | n = 5 (6.4 %) |
Localisation of primary tumor (%) | |
Oral cavity | n = 12 (15.4 %) |
Pharynx | n = 63 (80.7 %) |
Paranasal sinus | n = 2 (2.6 %) |
Not available | n = 1 (1.3 %) |